Mo is a science entrepreneur with over 30 yearsβ experience in the pharmaceutical industry, having responsibilities as wide-ranging as R&D and innovation, business development and strategic alliances at Pharmidex. He was previously head of drug metabolism, DMPK/PD at Vernalis Research, before which he was DMPK team leader at Aventis Pharma (Sanofi). Mo is visiting Professor at University of Hertfordshire and a fellow of the Royal Society of Chemistry (FRSC) and the Royal Society for Medicine (FRSM).
EFMC β’
01/2017 β 01/2017 β’
Financial Management of European Commission Projects,
01/2014 β 01/2014 β’
International Business Growth
01/2012 β 01/2012 β’
Executive Education
University College, London β’
01/2010 β 01/2010 β’
Bioprocess Design & Economic Evaluation
Indian Institute of Management Ahmedabad β’
01/2009 β 01/2009 β’
Executive Education
University College London Institute of Neurology β’
01/1990 β 01/1992 β’
Clinical Neurology - TDM
UCL Institute of Neurology, University College London β’
01/1987 β 01/1990 β’
Clinical Neurology - TDM